Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 85% ± 16% | |
lung | 19 studies | 75% ± 18% | |
intestine | 13 studies | 70% ± 23% | |
brain | 12 studies | 35% ± 22% | |
eye | 10 studies | 52% ± 23% | |
kidney | 9 studies | 75% ± 18% | |
liver | 7 studies | 61% ± 26% | |
bone marrow | 6 studies | 69% ± 25% | |
lymph node | 6 studies | 90% ± 5% | |
pancreas | 5 studies | 77% ± 17% | |
placenta | 5 studies | 72% ± 32% | |
uterus | 5 studies | 84% ± 17% | |
adipose | 4 studies | 40% ± 28% | |
prostate | 4 studies | 78% ± 21% | |
breast | 4 studies | 88% ± 6% | |
heart | 3 studies | 41% ± 15% | |
adrenal gland | 3 studies | 73% ± 16% | |
esophagus | 3 studies | 73% ± 19% | |
skin | 3 studies | 76% ± 19% | |
thymus | 3 studies | 83% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 11511.81 | 2640 / 2642 | 86% | 2.19 | 607 / 705 |
pancreas | 100% | 8623.42 | 328 / 328 | 86% | 1.89 | 153 / 178 |
uterus | 100% | 16023.94 | 170 / 170 | 85% | 2.01 | 389 / 459 |
bladder | 100% | 13729.71 | 21 / 21 | 78% | 1.88 | 392 / 504 |
thymus | 100% | 15405.85 | 653 / 653 | 76% | 1.55 | 460 / 605 |
lung | 100% | 12234.88 | 578 / 578 | 75% | 1.91 | 870 / 1155 |
intestine | 100% | 12538.02 | 966 / 966 | 73% | 1.59 | 386 / 527 |
breast | 100% | 16125.53 | 459 / 459 | 72% | 1.49 | 804 / 1118 |
ovary | 100% | 20300.60 | 180 / 180 | 68% | 1.21 | 291 / 430 |
skin | 100% | 13255.40 | 1809 / 1809 | 67% | 1.47 | 315 / 472 |
esophagus | 100% | 11881.11 | 1445 / 1445 | 67% | 1.09 | 122 / 183 |
prostate | 100% | 15233.83 | 245 / 245 | 60% | 1.02 | 301 / 502 |
adrenal gland | 100% | 13615.92 | 258 / 258 | 59% | 1.05 | 135 / 230 |
kidney | 100% | 13057.18 | 89 / 89 | 58% | 1.49 | 520 / 901 |
stomach | 100% | 10140.43 | 359 / 359 | 55% | 1.12 | 158 / 286 |
liver | 100% | 5029.87 | 226 / 226 | 28% | 0.50 | 112 / 406 |
adipose | 100% | 14915.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14260.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 15669.37 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.85 | 1 / 1 |
muscle | 99% | 8875.47 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 8229.80 | 853 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 2.45 | 25 / 29 |
peripheral blood | 85% | 6098.17 | 790 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 67% | 1.37 | 30 / 45 |
eye | 0% | 0 | 0 / 0 | 39% | 0.82 | 31 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1990114 | Biological process | RNA polymerase II core complex assembly |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_1990115 | Biological process | RNA polymerase III assembly |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0006457 | Biological process | protein folding |
GO_1990113 | Biological process | RNA polymerase I assembly |
GO_1905907 | Biological process | negative regulation of amyloid fibril formation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0016272 | Cellular component | prefoldin complex |
GO_0045111 | Cellular component | intermediate filament cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PFDN5 |
Protein name | Prefoldin subunit 5 (Myc modulator 1) (c-Myc-binding protein Mm-1) Prefoldin subunit 5 |
Synonyms | PFD5 MM1 hCG_23361 |
Description | FUNCTION: Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. Represses the transcriptional activity of MYC. . |
Accessions | ENST00000334478.9 [Q99471-1] ENST00000552742.6 ENST00000708930.1 [Q99471-3] ENST00000708936.1 [Q99471-2] F8VNW6 ENST00000551018.5 [Q99471-1] Q99471 ENST00000550846.5 H3BPF6 A0A7I2V5H9 ENST00000708937.1 [Q99471-1] ENST00000676468.1 ENST00000628881.2 H3BMQ1 ENST00000549759.2 ENST00000243040.10 [Q99471-2] ENST00000550880.5 F8VQZ2 ENST00000708922.1 [Q99471-1] ENST00000547130.6 A0A0D9SFR8 ENST00000351500.7 [Q99471-3] |